Boutin JA - Search Results

1

Alternative Ligands at Melatonin Receptors.

Legros C, Yous S, Boutin JA. Legros C, et al. Among authors: boutin ja. Methods Mol Biol. 2022;2550:151-162. doi: 10.1007/978-1-0716-2593-4_19. Methods Mol Biol. 2022. PMID: 36180688

2

Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.

Boutin JA, Lahaye C, Pegurier C, Nicolas JP, Fauchere JL, Langlois M, Renard P, Delagrange P, Canet E. Boutin JA, et al. J Recept Signal Transduct Res. 2000 Jan;20(1):105-18. doi: 10.3109/10799890009150040. J Recept Signal Transduct Res. 2000. PMID: 10711500

3

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA. Nosjean O, et al. Among authors: boutin ja. J Biol Chem. 2000 Oct 6;275(40):31311-7. doi: 10.1074/jbc.M005141200. J Biol Chem. 2000. PMID: 10913150 Free article.

4

Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2.

Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JA. Nosjean O, et al. Among authors: boutin ja. Biochem Pharmacol. 2001 Jun 1;61(11):1369-79. doi: 10.1016/s0006-2952(01)00615-3. Biochem Pharmacol. 2001. PMID: 11331072

5

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

Leclerc V, Yous S, Delagrange P, Boutin JA, Renard P, Lesieur D. Leclerc V, et al. Among authors: boutin ja. J Med Chem. 2002 Apr 25;45(9):1853-9. doi: 10.1021/jm011053+. J Med Chem. 2002. PMID: 11960497

6

Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.

Yous S, Durieux-Poissonnier S, Lipka-Belloli E, Guelzim H, Bochu C, Audinot V, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Yous S, et al. Among authors: boutin ja. Bioorg Med Chem. 2003 Mar 6;11(5):753-9. doi: 10.1016/s0968-0896(02)00473-x. Bioorg Med Chem. 2003. PMID: 12538005

7

Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands.

Descamps-François C, Yous S, Chavatte P, Audinot V, Bonnaud A, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Descamps-François C, et al. Among authors: boutin ja. J Med Chem. 2003 Mar 27;46(7):1127-9. doi: 10.1021/jm0255872. J Med Chem. 2003. PMID: 12646022

8

Design, synthesis and in vitro evaluation of novel derivatives as serotonin N-acetyltransferase inhibitors.

Beaurain N, Mésangeau C, Chavatte P, Ferry G, Audinot V, Boutin JA, Delagrange P, Bennejean C, Yous S. Beaurain N, et al. Among authors: boutin ja. J Enzyme Inhib Med Chem. 2002 Dec;17(6):409-14. doi: 10.1080/1475636021000005721. J Enzyme Inhib Med Chem. 2002. PMID: 12683677

9

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

Audinot V, Mailliet F, Lahaye-Brasseur C, Bonnaud A, Le Gall A, Amossé C, Dromaint S, Rodriguez M, Nagel N, Galizzi JP, Malpaux B, Guillaumet G, Lesieur D, Lefoulon F, Renard P, Delagrange P, Boutin JA. Audinot V, et al. Among authors: boutin ja. Naunyn Schmiedebergs Arch Pharmacol. 2003 Jun;367(6):553-61. doi: 10.1007/s00210-003-0751-2. Epub 2003 May 23. Naunyn Schmiedebergs Arch Pharmacol. 2003. PMID: 12764576

10

Design, synthesis and in vitro evaluation of novel benzo[b]thiophene derivatives as serotonin N-acetyltransferase (AANAT) inhibitors.

Mesangeau C, Yous S, Chavatte P, Ferry G, Audinot V, Boutin JA, Delagrange P, Bennejean C, Renard P, Lesieur D. Mesangeau C, et al. Among authors: boutin ja. J Enzyme Inhib Med Chem. 2003 Apr;18(2):119-25. doi: 10.1080/1475636031000093552. J Enzyme Inhib Med Chem. 2003. PMID: 12943195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page